All sponsors

Viatris Innovation GmbH

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-35
RECRUITING1
READOUTS ≤12 MONTHS3
READOUT SLIPPED >6 MO80%

Delay Index: of 5 active trials registered more than a year ago, 4 have moved their primary completion (readout) date by more than 6 months since first registration (median +19.9 months). See all sponsors →

Open Viatris Innovation GmbH on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
OPUS-2
NCT05672576
P3Active, not recruitingLupus Erythematosus, Systemic4512026-12-31 (+18 mo)
OPUS-1
NCT05648500
P3Active, not recruitingLupus Erythematosus, Systemic4702027-03-31 (+20 mo)
SOS-AMI
NCT04957719
P3Enrolling by invitationAcute Myocardial Infarction250002027-07 (+41 mo)
LUMIOS
NCT07201129
P3RecruitingNephritis, Lupus; Lupus Erythematosus, Systemic3002029-08
OPUS OLE
NCT06475742
P3Enrolling by invitationLupus Erythematosus, Systemic6802032-09 (+58 mo)